ADIPONECTIN BLOOD LEVEL AT PATIENTS WITH ESSENTIAL HYPERTENSION AND THE METABOLIC SYNDROME DURING OLMESARTAN THERAPY DINAMICS

被引：0
|
作者：
Malaczynska-Rajpold, K.
Woznicka-Leskiewicz, L. [1 ]
Kuczmarska, A.
Lipska, I.
Janura, J.
Klorek, I. [1 ]
机构：
[1] Univ Med Sci, Dept Hypertens Angiol & Internal Dis, Poznan, Poland
来源：
JOURNAL OF HYPERTENSION | 2010年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R6 [外科学];
学科分类号：
1002 ; 100210 ;
摘要：
引用
收藏
页码：E564 / E564
页数：1
相关论文
共 50 条
  • [1] 7.20 Adiponectin Gene Variants in the Metabolic Syndrome of Patients with Primary Aldosteronism and Essential Hypertension
    V. Ronconi
    F. Turchi
    S. Rilli
    L. Agostinelli
    M. Boscaro
    G. Giacchetti
    High Blood Pressure & Cardiovascular Prevention, 2007, 14 (3) : 145 - 145
  • [2] Metabolic syndrome in patients with essential hypertension
    Vigoa, AV
    Cruz, AV
    Calderín, RO
    Buchaca, EF
    Alvarez, NMC
    Paneque, RJ
    Luño, J
    NEFROLOGIA, 2003, 23 (05): : 423 - 431
  • [3] Clinical Outcomes of Olmesartan/Rosuvastatin Combination Therapy in Acute Coronary Syndrome Patients With Essential Hypertension
    Yang, In-Ho
    Cho, Jin-Man
    AMERICAN JOURNAL OF THERAPEUTICS, 2022, 29 (06) : E681 - E684
  • [4] Olmesartan improves the insulin resistance and inflammation in patients with hypertension and metabolic syndrome
    Albarran, Olga Gonzalez
    Paniagua, Amalia
    Lahera, Marcos
    Aragon, Carmen
    Calle, Hermenegildo
    Sanchorof, Jose
    DIABETES, 2008, 57 : A601 - A602
  • [5] Olmesartan improves the insulin resistance and inflammation in patients with hypertension and metabolic syndrome
    Gonzalez-Albarran, O.
    Paniagua, A.
    Lahera, M.
    Aragon, C.
    de la Calle, H.
    Alpanes, M.
    Rof, J. M. Sancho
    JOURNAL OF HYPERTENSION, 2008, 26 : S354 - S354
  • [6] Prevalence of metabolic syndrome in patients with essential hypertension
    Papadakis, John
    Vrentzos, George
    Repa, Argyro
    Sidiropoulou, Barbara
    Spanakis, Elias
    Ganotakis, Emmanouel
    JOURNAL OF HYPERTENSION, 2006, 24 : 194 - 194
  • [7] PREVALENCE OF THE METABOLIC SYNDROME IN ESSENTIAL HYPERTENSION PATIENTS
    Klosi, J.
    Bare, O.
    Gjata, M.
    Tase, M.
    JOURNAL OF HYPERTENSION, 2010, 28 : E580 - E580
  • [8] Metabolic syndrome in primary aldosteronism and essential hypertension: Relationship to adiponectin gene variants
    Ronconi, V.
    Turchi, F.
    Rilli, S.
    Di Mattia, D.
    Agostinelli, L.
    Boscaro, M.
    Giacchetti, G.
    NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES, 2010, 20 (02) : 93 - 100
  • [9] Adiponectin resistance parameter as a marker for high normal blood pressure an hypertension in patients with metabolic syndrome
    Stojanovic, S.
    Deljanin-Ilic, M.
    Ilic, S.
    Stefanovic, M.
    Petrovic, D.
    Petrovic, V
    Stojanovic, M.
    HIPPOKRATIA, 2020, 24 (01) : 3 - 7
  • [10] Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension
    Ruilope, Luis M.
    VASCULAR HEALTH AND RISK MANAGEMENT, 2008, 4 (06) : 1237 - 1248
12345